Concord Medical Services (CCM) Stock Price, News & Analysis

Company Overview

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China. The company typically partners with top-tier public hospitals to establish dedicated radiotherapy departments, combining its proprietary equipment management system with on-site technical teams. This collaborative approach allows hospital partners to expand access to high-precision treatment modalities, while Concord Medical Services oversees installation, quality assurance and ongoing clinical training for medical staff.

In addition to equipment provision, Concord Medical Services offers comprehensive consulting services that encompass treatment protocol design, dosimetry verification and patient data management. The company’s technology platform integrates imaging, treatment planning and delivery data, enabling clinicians to streamline workflows and monitor outcomes in real time. Concord Medical Services also provides preventive maintenance and rapid-response repair services, ensuring minimal downtime for critical cancer therapy equipment.

Since its initial public offering on the New York Stock Exchange in 2016, Concord Medical Services has continued to expand its footprint by pursuing new hospital partnerships and exploring advanced modalities such as image-guided radiotherapy and proton therapy. With a focus on innovation and quality assurance, the company aims to address the growing demand for precision oncology services across China’s rapidly aging and urbanizing population.

Key Stats

• Today's Range: $5.46 to $5.71
• 50-Day Range: $4.96 to $6.01
• 52-Week Range: $3.80 to $10.77
• Volume: 1,336 shs
• Average Volume: 2,001 shs
• Market Capitalization: $23.18 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Concord Medical Services Stock Analysis - MarketRank™

Concord Medical Services scored higher than 27% of companies evaluated by MarketBeat, and ranked 849th out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Concord Medical Services.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Concord Medical Services has a P/B Ratio of 0.10. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.13% of the float of Concord Medical Services has been sold short.

Short Interest Ratio / Days to Cover

Concord Medical Services has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Concord Medical Services has recently decreased by 21.05%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Concord Medical Services does not currently pay a dividend.

Dividend Growth

Concord Medical Services does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.13% of the float of Concord Medical Services has been sold short.

Short Interest Ratio / Days to Cover

Concord Medical Services has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Concord Medical Services has recently decreased by 21.05%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.87

News Sentiment

Concord Medical Services has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Concord Medical Services this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Concord Medical Services insiders have not sold or bought any company stock.

Percentage Held by Insiders

46.50% of the stock of Concord Medical Services is held by insiders. A high percentage of insider ownership can be a sign of company health.

CCM Stock Analysis - Frequently Asked Questions

How have CCM shares performed this year?

Concord Medical Services' stock was trading at $5.38 at the beginning of 2025. Since then, CCM shares have decreased by 0.7% and is now trading at $5.34.

How were Concord Medical Services' earnings last quarter?

Concord Medical Services Holdings Limited (NYSE:CCM) issued its earnings results on Wednesday, August, 24th. The company reported ($0.60) EPS for the quarter, missing the consensus estimate of $2.10 by $2.70. The business had revenue of $18.93 million for the quarter.

When did Concord Medical Services' stock split?

Shares of Concord Medical Services reverse split on the morning of Tuesday, July 30th 2024.The 1-10 reverse split was announced on Tuesday, July 30th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 30th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Concord Medical Services?

Shares of CCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Concord Medical Services own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Concord Medical Services investors own include M&T Bank (MTB), Carlyle Group (CG), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD), Crescent Biopharma (CBIO) and Chevron (CVX).

Company Calendar

• Last Earnings: 8/24/2016
• Today: 9/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - NURSING HMS
• Sub-Industry: Healthcare
• Current Symbol: NYSE:CCM
• CIK: 1472072
• Web: www.concordmedical.com
• Phone: 861059036688
• Fax: 86-10-5957-5252
• Employees: 970
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1.67
• Current Ratio: 0.46
• Quick Ratio: 0.45

Sales & Book Value

• Annual Sales: $52.60 million
• Price / Sales: 0.44
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $51.05 per share
• Price / Book: 0.10

Miscellaneous

• Outstanding Shares: 4,340,000
• Free Float: 2,323,000
• Market Cap: $23.18 million
• Optionable: Not Optionable
• Beta: -1.04